论文部分内容阅读
目的观察支原体宫颈炎患者采用阿希米进行治疗的临床效果。方法随机抽取我院2011年3月~2013年10月收治的80例支原体宫颈炎患者,根据患者治疗方法的区别,分成观察组与对照组,对照组采用司帕沙星片给予临床治疗,观察组在对照组治疗基础上采用阿希米联合进行治疗,对比两组患者治疗效果。结果观察组总有效率为95%,对照组总有效率为75%,观察组治疗效果明显优于对照组,组间数据对比差异明显(P<0.05)。结论支原体宫颈炎患者采用阿希米药物给予临床治疗,获得治疗效果较为明显,能加快患者疾病康复的速度,值得临床推广。
Objective To observe the clinical effect of using Asimi in patients with Mycoplasma cervicitis. Methods Eighty patients with mycoplasma cervicitis who were treated in our hospital from March 2011 to October 2013 were randomly divided into observation group and control group according to the difference of patients’ treatment methods. The control group was given sparfloxacin tablets for clinical treatment and observation The patients in the control group were treated with combination of Asimi on the basis of the control group, and the treatment effect was compared between the two groups. Results The total effective rate was 95% in the observation group and 75% in the control group. The treatment effect in the observation group was significantly better than that in the control group, with significant difference (P <0.05). Conclusion Mycoplasma cervicitis patients with Asimi drug clinical treatment, access to treatment is more obvious, can speed up the recovery of patients with disease, worthy of clinical promotion.